Sectors
IDYA
IDEAYA Biosciences, Inc.
35.30
1 x 35.29
1 x 35.84
bid
ask
-
0.69
1.92%
10:03 AM
timesize
| Ytd | 2.11% | |
| 1y | 60.31% |
35.58
day range
35.83
21.50
52 week range
40.58
| Open | 35.68 | Prev Close | 35.99 | Low | 35.58 | High | 35.83 | Mkt Cap | 3.42B |
| Vol | 16.27K | Avg Vol | 1.13M | EPS | -1.60 | P/E | -22.49 | Forward P/E | 4.65 |
| Beta | -0.09 | Short Ratio | 6.53 | Inst. Own | 101.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-05 | 50-d Avg | 32.30 | 200-d Avg | 32.38 | 1yr Est | 52.29 |
| Income Statement | |||
| Total Revenue | 6.56M | ||
| Revenues (USD) | 6.56M | ||
| Gross Profit | 6.56M | ||
| Operating Expenses | 115.10M | ||
| Research and Development Expense | 95.73M | ||
| Selling, General and Administrative Expense | 19.38M | ||
| Operating Income | -108.54M | ||
| Net Income | -98.54M | ||
| Net Income Common Stock | -98.54M | ||
| Net Income Common Stock (USD) | -98.54M | ||
| Consolidated Income | -98.54M | ||
| Earnings per Basic Share | -1.11 | ||
| Earnings per Basic Share (USD) | -1.11 | ||
| Earnings per Diluted Share | -1.11 | ||
| Earning Before Interest & Taxes (EBIT) | -98.54M | ||
| Earning Before Interest & Taxes (USD) | -98.54M | ||
| Weighted Average Shares | 88.70M | ||
| Weighted Average Shares Diluted | 88.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 158.80M | ||
| Cash and Equivalents (USD) | 158.80M | ||
| Investments | 815.39M | ||
| Investments Current | 513.68M | ||
| Investments Non-Current | 301.71M | ||
| Current Assets | 696.11M | ||
| Property, Plant & Equipment Net | 31.25M | ||
| Total Assets | 1.03B | ||
| Debt Current | 350.00K | ||
| Total Debt | 28.60M | ||
| Current Liabilities | 64.83M | ||
| Debt Non-Current | 28.25M | ||
| Total Liabilities | 93.08M | ||
| Accumulated Retained Earnings (Deficit) | -835.08M | ||
| Accumulated Other Comprehensive Income | -494.00K | ||
| Shareholders Equity | 937.27M | ||
| Shareholders Equity (USD) | 937.27M | ||
| Assets Non-Current | 334.24M | ||
| Total Debt (USD) | 28.60M | ||
| Liabilities Non-Current | 28.25M | ||
| Trade and Non-Trade Payables | 20.74M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.14M | ||
| Net Cash Flow from Financing | 1.18M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 44.96M | ||
| Capital Expenditure | -967.00K | ||
| Issuance (Purchase) of Equity Shares | 1.18M | ||
| Net Cash Flow from Investing | 118.95M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 119.92M | ||
| Net Cash Flow from Operations | -75.17M | ||
| Share Based Compensation | 14.54M | ||